Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.570
-0.040-0.87%
Volume:6.97M
Turnover:31.95M
Market Cap:28.71B
PE:6.10
High:4.640
Open:4.600
Low:4.555
Close:4.610
52wk High:6.336
52wk Low:4.211
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:0.63
T/O Rate:0.11%
Dividend:0.22
Dividend Rate:4.77%
EPS(LYR):0.750
ROE:8.32%
ROA:2.64%
PB:0.47
PE(LYR):6.10
PS:0.09

Loading ...

Earnings Miss: China Resources Pharmaceutical Group Limited Missed EPS By 12% And Analysts Are Revising Their Forecasts

Simply Wall St.
·
Aug 27

BofA Securities Trims China Resources Pharma Price Target to HK$5.7, Keeps Buy Rating

Stock News
·
Aug 26

China Resources Pharmaceutical Group (SEHK:3320) Stock Trades Cheap As Margin Recovery Seeks Credibility

Simply Wall St.
·
Aug 25

CHINARES PHARMA declares RMB 0.087 interim dividend for H1 2026; payment set for 30 October 2026

Bulletin Express
·
Aug 24

CHINARES PHARMA Posts Stable 1H26 Results; Revenue Rises to RMB 134.46 Billion, Interim Dividend Up 21%

Bulletin Express
·
Aug 24

China Resources Pharma Reports 5.3% Rise in Interim Net Profit to HK$2.187 Billion

Stock News
·
Aug 24

China Resources Pharmaceutical Sets October 30 Payout for Interim Dividend

Stock News
·
Aug 24

China Resources Pharmaceutical Group Declares Interim Dividend of Rmb0.087 Per Share

Reuters
·
Aug 24

China Resources Pharmaceutical Declared an Interim Dividend of Rmb0.087 Per Share

THOMSON REUTERS
·
Aug 24

China Resources Pharmaceutical Group H1 Revenue RMB 134,457.6 Million

THOMSON REUTERS
·
Aug 24

China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion for CR Jiangzhong

Reuters
·
Aug 21

KPC Pharmaceuticals Posts H1 2026 Net Loss of RMB 0.36 Billion as Revenue Falls 51%

Bulletin Express
·
Aug 21

CR Sanjiu posts 1.37% H1 2026 revenue growth; net profit slips 7.96%

Bulletin Express
·
Aug 21

China Resources Pharma Reports Interim Results: Subsidiary Net Profit Dips Nearly 8%

Stock News
·
Aug 21

China Resources Pharmaceutical Group - Six-Month Revenue RMB 1.64 Bln, Down 50.97% for Kpc Pharmaceuticals

THOMSON REUTERS
·
Aug 21

CR Pharma Reports 4.91B Yuan Net Profit for Jiangzhong Unit in First Half, Down 5.92%

Stock News
·
Aug 21

China Resources Pharmaceutical - Cr Jiangzhong Proposed to Distribute Cash Dividend of RMB5 for Every 10 Shares

THOMSON REUTERS
·
Aug 21

China Resources Pharmaceutical Group - H1 2026 Revenue Down 2.03% to RMB 4.20 Bln for Tasly Pharmaceutical

THOMSON REUTERS
·
Aug 21

CR Boya Bio-Pharmaceutical, China Resources Pharmaceutical Subsidiary, Posts 77.28% Drop in H1 Net Profit Attributable to Shareholders to RMB 51.19 Million

Reuters
·
Aug 21

China Resources Medical Names Yu Changjiu CFO Effective Aug. 20, 2026

Reuters
·
Aug 20